News

More billionaire immigrants come from India than anywhere else in the world followed by two much smaller spots tied at number ...
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...
PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr.
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...
Armenia’s AI leap, backed by its diaspora, has sparked a regional tech race, with Türkiye eyeing a strategic response ...
Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...
Global recognition affirms Tyme’s mission to serve entire populations and unlock human potential through digital banking. Tyme Group, the major ...
Engineers and plant scientists worked together to improve a basic tool of plant research. The result is more efficient and ...
Forbes’ 2025 list highlights 125 foreign-born U.S. billionaires, including three Greeks: John Catsimatidis, C. Dean ...